Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.4M
-
Number of holders
-
408
-
Total 13F shares, excl. options
-
24.9M
-
Shares change
-
+621K
-
Total reported value, excl. options
-
$4.67B
-
Value change
-
+$108M
-
Put/Call ratio
-
1.89
-
Number of buys
-
214
-
Number of sells
-
-184
-
Price
-
$188.05
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q1 2023
470 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q1 2023.
Medpace Holdings, Inc. - Common Stock (MEDP) has 408 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
of 28.4M outstanding shares and own 87.46% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.18M shares), VANGUARD GROUP INC (2.66M shares), WASATCH ADVISORS LP (1.86M shares), FULLER & THALER ASSET MANAGEMENT, INC. (940K shares), STATE STREET CORP (841K shares), GEODE CAPITAL MANAGEMENT, LLC (588K shares), Boston Trust Walden Corp (563K shares), GOLDMAN SACHS GROUP INC (549K shares), DIMENSIONAL FUND ADVISORS LP (541K shares), and RIVERBRIDGE PARTNERS LLC (441K shares).
This table shows the top 408 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.